Jieyao Li

943 total citations · 1 hit paper
14 papers, 416 citations indexed

About

Jieyao Li is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jieyao Li has authored 14 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Jieyao Li's work include Epigenetics and DNA Methylation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Jieyao Li is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Jieyao Li collaborates with scholars based in China, United States and Belgium. Jieyao Li's co-authors include Liping Wang, Yi Zhang, Dongli Yue, Xinfeng Chen, Ping Yü, Lan Huang, Lifeng Li, Bin Zhang, Feng Li and Qi‐Kui Chen and has published in prestigious journals such as Immunity, International Journal of Cancer and Experimental Cell Research.

In The Last Decade

Jieyao Li

14 papers receiving 412 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis

2024 59 citations Yu P, Feng Li et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jieyao Li China	12	195	155	122	113	91	14	416
Handan Xiang United States	8	236 1.2×	146 0.9×	149 1.2×	105 0.9×	29 0.3×	10	424
Diane Costanzo-Garvey United States	9	118 0.6×	122 0.8×	80 0.7×	53 0.5×	42 0.5×	12	283
Laxminarasimha Donthireddy United States	7	157 0.8×	220 1.4×	351 2.9×	98 0.9×	56 0.6×	11	562
Peter Zentis Germany	9	186 1.0×	135 0.9×	99 0.8×	34 0.3×	41 0.5×	12	446
Emma Kurz United States	6	138 0.7×	170 1.1×	134 1.1×	55 0.5×	33 0.4×	11	354
Asel Biktasova United States	9	260 1.3×	157 1.0×	166 1.4×	78 0.7×	48 0.5×	10	502
Hassan Fazilaty Iran	12	239 1.2×	183 1.2×	36 0.3×	92 0.8×	36 0.4×	25	405
Xinyue Lv China	10	160 0.8×	62 0.4×	134 1.1×	75 0.7×	33 0.4×	27	366
Kristofer C. Berrett United States	9	287 1.5×	87 0.6×	39 0.3×	89 0.8×	45 0.5×	13	447

Countries citing papers authored by Jieyao Li

Since Specialization

Citations

This map shows the geographic impact of Jieyao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieyao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieyao Li more than expected).

Fields of papers citing papers by Jieyao Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieyao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieyao Li. The network helps show where Jieyao Li may publish in the future.

Co-authorship network of co-authors of Jieyao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jieyao Li. A scholar is included among the top collaborators of Jieyao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieyao Li. Jieyao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

P, Yu, Feng Li, Jiao Qu, et al.. (2024). PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis. Immunity. 57(9). 2122–2139.e9. 59 indexed citations breakdown →

Liu, Xiaoyu, et al.. (2023). Predictive factors and prognosis of immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer patients. Frontiers in Oncology. 13. 1145143–1145143. 5 indexed citations

Yü, Ping, Yaqing Liu, Zhangnan Liu, et al.. (2022). Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell function. Cancer Immunology Immunotherapy. 72(4). 1015–1027. 31 indexed citations

Gu, Zhuoyu, Liping Wang, Xiaohan Yao, et al.. (2020). ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma. Cell Death and Disease. 11(10). 898–898. 18 indexed citations

Miao, Wei, Lina Guo, Wenhua Xue, et al.. (2019). <p>Type C Personality and Depression Among Newly Diagnosed Breast Cancer Patients: The Mediating Role of Sense of Coherence</p>. Neuropsychiatric Disease and Treatment. Volume 15. 3519–3529. 11 indexed citations

Zhang, Chaoyang, Feng Li, Jieyao Li, et al.. (2018). Docetaxel Down-Regulates PD-1 Expression via STAT3 in T Lymphocytes. Clinical Lung Cancer. 19(5). e675–e683. 13 indexed citations

Xu, Jihao, Wa Zhong, Zhong‐Sheng Xia, et al.. (2017). Sox9 transcriptionally regulates Wnt signaling in intestinal epithelial stem cells in hypomethylated crypts in the diabetic state. Stem Cell Research & Therapy. 8(1). 60–60. 20 indexed citations

Chen, Xinfeng, Liping Wang, Jinyan Liu, et al.. (2017). Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer. Oncology Letters. 13(3). 1609–1618. 38 indexed citations

Li, Lifeng, Jingli Lü, Wenhua Xue, et al.. (2017). Target of obstructive sleep apnea syndrome merge lung cancer: based on big data platform. Oncotarget. 8(13). 21567–21578. 38 indexed citations

10.

Li, Lifeng, Yang Li, Liping Wang, et al.. (2016). Impaired T cell function in malignant pleural effusion is caused by TGF‐β derived predominantly from macrophages. International Journal of Cancer. 139(10). 2261–2269. 71 indexed citations

11.

Shan, Ti‐Dong, Hui Ouyang, Tao Yu, et al.. (2016). miRNA‐30e regulates abnormal differentiation of small intestinal epithelial cells in diabetic mice by downregulating Dll4 expression. Cell Proliferation. 49(1). 102–114. 27 indexed citations

12.

Yue, Dongli, Zhen Zhang, Jieyao Li, et al.. (2015). Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer. Experimental Cell Research. 336(1). 141–149. 40 indexed citations

13.

Yue, Dongli, Xinfeng Chen, Liping Wang, et al.. (2014). Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity. Oncology Reports. 33(1). 425–432. 35 indexed citations

14.

Li, Jieyao, Tao Yu, Zhong‐Sheng Xia, et al.. (2014). Enhanced proliferation in colorectal epithelium of patients with type 2 diabetes correlates with β-catenin accumulation. Journal of Diabetes and its Complications. 28(5). 689–697. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact